lysophosphatidic acid has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, DD; Barnholtz-Sloan, J; Chance, MR; Chen, Y; Davitkov, P; Funderburg, N; Hazlett, FE; Lederman, MM; Rodriguez, B; Schlatzer, DM; Sieg, SF; Sugalski, JM | 1 |
| Anthony, DD; Chance, MR; Compan, A; Falck-Ytter, Y; Hirsch, A; Judge, C; Kostadinova, L; Li, X; Popkin, DL; Rife, K; Rodriguez, B; Schlatzer, DM; Shive, CL; Zebrowski, E | 1 |
2 other study(ies) available for lysophosphatidic acid and HIV Coinfection
| Article | Year |
|---|---|
Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections.
Topics: Adult; Biomarkers; Coinfection; Cyclic Nucleotide Phosphodiesterases, Type 2; Female; Hepatitis C, Chronic; HIV Infections; Humans; Lysophospholipids; Male; Middle Aged; Plasma; Proteome | 2013 |
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Coinfection; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Interleukin-6; Lipopolysaccharide Receptors; Lysophospholipids; Male; Middle Aged; Monocytes; Phosphoric Diester Hydrolases; Plasma; Receptors, Cell Surface | 2016 |